THE DISCOVERY AND DEVELOPMENT OF BUSPIRONE - A NEW APPROACH TO THE TREATMENT OF ANXIETY

被引：72

作者：

NEW, JS

机构：

[1] Preclinical CNS Research, Pharmaceutical Research and Development Division, Bristol-Myers Squibb Co., Wallingford, Connecticut

来源：

MEDICINAL RESEARCH REVIEWS | 1990年 / 10卷 / 03期

关键词：

D O I：

10.1002/med.2610100302

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：283 / 326

页数：44

共 173 条

[1] POLYCYCLIC ARYLPIPERAZINYL AND HETEROARYLPIPERAZINYL IMIDES AS 5-HT1A RECEPTOR LIGANDS AND POTENTIAL ANXIOLYTIC AGENTS - SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES [J].

ABOUGHARBIA, M ;

PATEL, UR ;

WEBB, MB ;

MOYER, JA ;

ANDREE, TH ;

MUTH, EA .

JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (07) :1382-1392

[2]

ABOUGHARBIA M, 1986, Patent No. 2181731

[3] SUPPRESSION OF LORDOSIS BEHAVIOR BY THE PUTATIVE 5-HT RECEPTOR AGONIST 8-OH-DPAT IN THE RAT [J].

AHLENIUS, S ;

FERNANDEZGUASTI, A ;

HJORTH, S ;

LARSSON, K .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 124 (03) :361-363

[4] MULTIPLE AND COMPLEX EFFECTS OF BUSPIRONE ON CENTRAL DOPAMINERGIC SYSTEM [J].

ALGERI, S ;

DELUIGI, A ;

DESIMONI, MG ;

IMERI, L ;

MARCONI, M ;

NAVA, S ;

PEREGO, C ;

SACCHETTI, G .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (04) :823-826

[5]

ALLEN LE, 1974, ARZNEIMITTEL-FORSCH, V24, P917

[6] CENTRAL NORADRENERGIC MECHANISM INVOLVED IN HALOPERIDOL-INDUCED CATALEPSY IN RAT [J].

ALSHABIBI, UMH ;

DOGGETT, NS .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (08) :529-531

[7]

AMSTERDAM JD, 1987, CURR THER RES CLIN E, V41, P185

[8]

ANDRADE R, 1987, N-S ARCH PHARMACOL, V336, P5

[9]

ANDREE TH, 1987, PHARMACOLOGIST, V29, P112

[10]

ANTOKU F, 1987, Patent No. 261688

← 1 2 3 4 5 6 7 8 9 10 →